［1］Freedman MS. Long-term follow-up of clinical trials of multiple sclerosis therapies［J］. Neurology, 2011, 76(1 Suppl 1): S26-S34.

［2］熊晖,张月华,周蕊,包新华,姜玉武,吴晔,等.儿童多发性硬化的临床特点及治疗［J］.中华儿科杂志,2007,45(8):568-573.

［3］Poman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "Mcdonald Griterial"［J］. Ann Neurol, 2005, 58(6): 840-846.

［4］杨锡强.儿童多发性硬化发病机制和诊断治疗研究进展［J］.中国实用儿科杂志，2003,18(2):70-73.

［5］黄德晖,吴卫平,蒲传强.多发性硬化226例临床分析［J］.中国神经免疫学和神经病学杂志，2003,10(3):152-155.

［6］Chabas D, Strober J, Waubant E. Pediatric multiple sclerosis［J］. Curr Neurol Neurosci Rep, 2008, 8(5): 434-441.

［7］Hynson JL, Komberg AJ, Coleman LT. Clincal and neuroradiolo-gic features of acute disseminated encephalomyelitis in children ［J］. Neurology, 2001, 56(10): 1308-1312.

［8］金真.儿童多发性硬化的磁共振影像诊断［J］.实用儿科临床杂志,2005,20(4):297-299.

［9］Arnold DL, Matthews PM. MRI in the diagnosis and management of multiple sclerosis［J］. Neurology,2002,58(8 Suppl 4):S23-S31.

［10］王建军，黄越，邹丽萍.儿童脑血管炎诊断与鉴别诊断［J］.中国当代儿科杂志，2010,12(5):407-411.

［11］中华医学会神经病分会，中华神经科杂志编辑部.中国多发性硬化及相关中枢神经系统脱髓鞘疾病的诊断和治疗专家共识（草案）［J］.中华神经科杂志,2006,39（12）:862-864.

［12］Etemadifar M, Janghorbani M, Shaygannejad V. Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis［J］. Acta Neurol Scand, 2006, 113(5): 283-287.